fig2

Emerging treatments for systemic lupus erythematosus

Figure 2. Cytokine signaling mediated by JAK/TYK2 inhibitors. Some cytokines share receptors and transmit signals through common pathways. TYK2 inhibitors have a strong affinity for inhibiting cytokines from the IL-12/23 and IL-10 families. JAK: Janus kinase; TYK2: tyrosine kinase 2. Created in BioRender. Kanda, K. (2025) https://BioRender.com/a34j761.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/